Research Presentation Sessions: Abdominal Viscera & GI Tract

RPS 201 - Advances in imaging of hepatocellular carcinoma

Lectures

1
Risk factors of hepatocellular carcinoma after direct-acting antiviral treatment: a prospective multicentre study

Risk factors of hepatocellular carcinoma after direct-acting antiviral treatment: a prospective multicentre study

07:00Shintaro Ichikawa, Hamamatsu / JP

2
The feasibility of early response evaluation using Superb Microvascular Imaging one day after transcatheter arterial chemoembolisation for hepatocellular carcinoma

The feasibility of early response evaluation using Superb Microvascular Imaging one day after transcatheter arterial chemoembolisation for hepatocellular carcinoma

07:00Eo Ram Jeong, Busan / KR

3
Predicting overall survival after hepatocellular carcinoma resection using the COMA score: a dual-institutional study

Predicting overall survival after hepatocellular carcinoma resection using the COMA score: a dual-institutional study

07:00Hong Wei, Chengdu / CN

4
Risk stratification of solitary hepatocellular carcinoma ≤5 cm without microvascular invasion: prognostic values of MR imaging features and clinical parameters

Risk stratification of solitary hepatocellular carcinoma ≤5 cm without microvascular invasion: prognostic values of MR imaging features and clinical parameters

07:00Wang Leyao, Beijing / CN

5
Transversal psoas muscle thickness measurement is associated with response and survival in patients with hepatocellular carcinoma undergoing immunotherapy

Transversal psoas muscle thickness measurement is associated with response and survival in patients with hepatocellular carcinoma undergoing immunotherapy

07:00Katharina Lampichler, Vienna / AT

6
The future of hepatocellular carcinoma screening: non-contrast abbreviated MRI versus dynamic abbreviated MRI

The future of hepatocellular carcinoma screening: non-contrast abbreviated MRI versus dynamic abbreviated MRI

07:00Raphaël Dominique Girardet, Lausanne / CH

7
Y-90 radioembolisation for intermediate to advanced hepatocellular carcinoma: AFP response patterns and correlation with radiologic disease progression

Y-90 radioembolisation for intermediate to advanced hepatocellular carcinoma: AFP response patterns and correlation with radiologic disease progression

07:00Justin Ruey Tse, Stanford / US

8
Deep learning model with convolutional neural network for detecting and segmenting hepatocellular carcinoma in CT: a preliminary study

Deep learning model with convolutional neural network for detecting and segmenting hepatocellular carcinoma in CT: a preliminary study

07:00Chien Cong Phan, Ho Chi Minh city / VN

9
Magnetic resonance elastography (MRE)-based nomogram for predicting proliferative hepatocellular carcinoma

Magnetic resonance elastography (MRE)-based nomogram for predicting proliferative hepatocellular carcinoma

07:00Guixue Liu, shanghai / CN

10
The value of Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5th edition of the World Health Organization (WHO) classification

The value of Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5th edition of the World Health Organization (WHO) classification

07:00Sebastian Halskov, Berlin / DE

11
CT radiomics for the prediction of microvascular invasion and survival in patients with HCC: is it a matter of chance or standardisation?

CT radiomics for the prediction of microvascular invasion and survival in patients with HCC: is it a matter of chance or standardisation?

07:00Roberto Cannella, Palermo / IT

12
Moderation

Moderation

00:00Federica Vernuccio, Padova / IT

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.